BSE filing, NSE: SANDUPHQ. Summary written from the filing by ALFA Finder's alert engine.
Sandu Pharmaceuticals Ltd: key numbers
- Share price
- ₹36.33
- Market cap
- ₹35.10 Cr
- Revenue (annual)
- ₹69.93 Cr
- Net profit (annual)
- ₹1.77 Cr
- P/E (TTM)
- 14.4×Sector 41.3×
- Promoter holding
- 37.79%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sandu Pharmaceuticals Ltd
All →Sandu Pharmaceuticals Other Announcement
The company submitted its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026.
Sandu Pharmaceuticals Other Announcement
Sandu Pharmaceuticals intimated that Non-Executive Independent Director Dr Neeti Madan Kapre has changed her name to Dr Neeti Gupta after marriage. The DIN, designation and directorship remain unchanged.
Sandu Pharmaceuticals Other Announcement
Sandu Pharmaceuticals Limited has issued a reminder to physical shareholders regarding the mandatory submission of PAN and KYC details. This compliance follow-up aims to facilitate electronic dividend payments.
Sandu Pharmaceuticals Management Change
Sandu Pharmaceuticals appointed Dr. Neeti Madan Kapre as director and Dave & Dave as statutory auditor, while announcing other board and auditor tenure changes.
Sandu Pharmaceuticals Other Announcement
Sandu Pharmaceuticals has appointed M/s. Dave & Dave as Statutory Auditors for a five-year term, following the tenure expiry of the previous auditors.
Sandu Pharmaceuticals Annual General Meeting
Sandu Pharmaceuticals Limited held its 41st Annual General Meeting on September 11, 2026, via video conferencing to transact ordinary and special business items.
Other board meeting date announcements
All →Kiran Print Pack Board Meeting Date
Kiran Print Pack Ltd notified BSE of a board meeting on 12 November 2026 to consider unaudited financial results for the quarter and half year ended 30 September 2026. No money or business event is announced.
Chambal Breweries & Distilleries Board Meeting Date
Chambal Breweries will hold a board meeting on November 10, 2026 to consider unaudited results. The results cover the half year ended September 30, 2026.
Vishwaraj Sugar Industries Board Meeting Date
Vishwaraj Sugar will hold a board meeting on 14 November 2026 to consider unaudited Q2 results. The trading window stays closed until 16 November 2026.
Pro Fin Capital Services Board Meeting Date
Pro Fin Capital Services notified BSE of a board meeting on 13 November 2026 to consider unaudited quarterly and half-year results for September 2026. The intimation carries no financial figures.
MAC Hotels Board Meeting Date
Mac Hotels Ltd intimated BSE of a board meeting on 12 November 2026 to approve unaudited standalone half-year results ended 30 September 2026. The filing itself reports no financial figures.
James Warren Tea Board Meeting Date
James Warren Tea will hold a board meeting on November 12, 2026 to consider unaudited September 2026 results. The trading window remains closed until results are announced.